Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lymphangioleiomyomatosis: a review.

Literature DB >> 9872207

Lymphangioleiomyomatosis: a review.

E J Sullivan¹.

Abstract

Entities: Disease

Mesh：

Year: 1998 PMID： 9872207 DOI： 10.1378/chest.114.6.1689

Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410

Keyword Cloud
Cited

× No keyword cloud information.

35 in total

1. Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.

Authors: Yoshihiko Ikeda; Angelo M Taveira-DaSilva; Gustavo Pacheco-Rodriguez; Wendy K Steagall; Souheil El-Chemaly; Bernadette R Gochuico; Rose M May; Olanda M Hathaway; Shaowei Li; Ji-an Wang; Thomas N Darling; Mario Stylianou; Joel Moss
Journal: Am J Physiol Lung Cell Mol Physiol Date: 2010-10-29 Impact factor: 5.464

Review 2. Lymphangioleiomyomatosis.

Authors: Francis X McCormack
Journal: MedGenMed Date: 2006-01-18

3. Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.

Authors: Souheil El-Chemaly; Angelo Taveira-Dasilva; Hilary J Goldberg; Elizabeth Peters; Mary Haughey; Don Bienfang; Amanda M Jones; Patricia Julien-Williams; Ye Cui; Julian A Villalba; Shefali Bagwe; Rie Maurer; Ivan O Rosas; Joel Moss; Elizabeth P Henske
Journal: Chest Date: 2017-02-10 Impact factor: 9.410

4. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Authors: T Carsillo; A Astrinidis; E P Henske
Journal: Proc Natl Acad Sci U S A Date: 2000-05-23 Impact factor: 11.205

Review 5. A practical approach to high-resolution CT of diffuse lung disease.

Authors: Mizuki Nishino; Harumi Itoh; Hiroto Hatabu
Journal: Eur J Radiol Date: 2013-02-11 Impact factor: 3.528

6. Interferon-gamma-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target.

Authors: Nisreen El-Hashemite; David J Kwiatkowski
Journal: Am J Respir Cell Mol Biol Date: 2005-06-30 Impact factor: 6.914

Lymphangioleiomyomatosis: a review.

1. Erythropoietin-driven proliferation of cells with mutations in the tumor suppressor gene TSC2.

Review 2. Lymphangioleiomyomatosis.

3. Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.

4. Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis.

Review 5. A practical approach to high-resolution CT of diffuse lung disease.

6. Interferon-gamma-Jak-Stat signaling in pulmonary lymphangioleiomyomatosis and renal angiomyolipoma: a potential therapeutic target.

7. Survival and disease progression in UK patients with lymphangioleiomyomatosis.

8. Assessment of patients with chronic obstructive pulmonary disease.

9. Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.

10. Association of retroperitoneal lymphangioleiomyomatosis with endosalpingiosis: a case report.